本页面由Tiger Trade Technology Pte. Ltd.提供服务

BIOTRON LIMITED

0.003
0.000
成交量:249.48万
成交额:7,470.00
市值:810.56万
市盈率:-2.06
高:0.003
开:0.003
低:0.002
收:0.003
52周最高:0.005
52周最低:0.002
股本:27.02亿
流通股本:11.65亿
量比:3.07
换手率:0.21%
股息:- -
股息率:- -
每股收益(TTM):-0.001
每股收益(LYR):0.000
净资产收益率:-122.62%
总资产收益率:-50.99%
市净率:3.00
市盈率(LYR):-9.43

数据加载中...

公司资料

公司名字:
BIOTRON LIMITED
交易所:
ASX
成立时间:
1999
员工人数:
3
公司地址:
66 Hunter Street,Level 2,Sydney,New South Wales,Australia
邮编:
2000
传真:
61 2 9221 6333
简介:
Biotron Limited, a biotechnology company, develops and commercializes novel small molecule antiviral therapeutics to treat various viral diseases in Australia. Its lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of HIV-1 and hepatitis C virus infections. The company also has a portfolio of preclinical antiviral programs developing drugs targeting a range of viral diseases, including Dengue, Zika, Influenza, Ebola, and SARs. Biotron Limited is based in North Ryde, Australia.